Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 280 No 7495 p358
29 March 2008

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Collection of data on patient outcomes will become routine, predicts OHE commission

Collection of data on patient outcomes will become routine for most conditions and NHS activity in the next five years, according to a health economics commission.

Within 10 years it will be common practice to collect data that measure the impact of NHS services on a patient in terms of their life expectancy, quality of life and the experience of their care, says a report from the Office of Health Economics commission on NHS outcomes, performance and productivity

The commission, set up in the autumn of 2006 to look at what patient data should and could be routinely collected and analysed in the NHS, concludes that measurement of patient outcomes is both “practical and essential”.

It predicts collecting data will bring better outcomes for patients as well as encourage better performance from providers and improve productivity costs.

The commissioners recommend that generic measures of health outcomes — such as those covering quality of life before, during and after treatment — should be collected as well as other groups of data that are disease-specific.

Data for patients suffering from long-term conditions, such as chronic obstructive pulmonary disease, should be collected at regular intervals, it recommends.

The commission also proposes that routine information should be collected about patients’ personal experience of their care, which should address issues such as access to care, personal dignity, choice and the support available for carers.

Back to Top


©The Pharmaceutical Journal